Dr. Nader N. Tobia, M.D. Internal Medicine Medicare: Accepting Medicare Assignments Practice Location: 114 N Orchard Dr, Park Forest, IL 60466 Phone: 708-283-3384 |
News Archive
StemCells, Inc., a leading stem cell company developing and commercializing novel stem cell therapeutics and tools for use in stem cell-based research and drug discovery, today reported financial results and business highlights for the second quarter ended June 30, 2010.
British researchers have discovered a new way of detecting which breast cancer patients are going to respond best to chemotherapy that includes anthracycline antibiotics. The study has found that an abnormality on chromosome 17, called CEP17, is not only associated with a worse outcome for patients, but also that its presence is a highly significant indicator that the tumour will respond to anthracyclines. The research will be presented at the European Breast Cancer Conference (EBCC7) Thursday 25th March.
Driver Aric Almirola is lending his voice to a national public education program to raise awareness of actinic keratosis (AK) - a potential early warning sign of skin cancer - as well as the long-term consequences of sun damage over a lifetime. The national campaign, "Is it AK or OK?" is sponsored by Graceway Pharmaceuticals, LLC, in partnership with The Skin Cancer Foundation.
In a paper recently uploaded to the preprint server medRxiv* by Chemaitelly et al. (August 27, 2021), the long-term effectiveness of the mRNA vaccines is analyzed amongst the Qatar population. The study observed waning protection against infection around six months post-vaccination but lasting protection from death and hospitalization.
A test to detect drug-resistant HIV strains in people with low levels of drug-resistant viral loads could help physicians provide more effective treatment earlier to HIV-positive people, according to a study published on Sunday in the online edition of the journal Nature Methods, BBC News reports.
› Verified 2 days ago